MYT1L and attention deficit-hyperactivity disorder: For MYT1L, our previously reported finding did not survive multiple-testing correction (minimum sex-by-diagnosis interaction p-value = 0.0039 for cg02870147; males Δβ = −0.49%), although the direction of effect at this site (lower methylation among males with ADHD) was consistent with our previous data, even with prior samples (n = 73) removed (males Δβ = −0.42%).